MedPath

Next Choice

These highlights do not include all the information needed to use Next Choice safely and effectively. See full prescribing information for Next Choice . Next Choice (levonorgestrel) Tablets, 0.75 mg, for oral use Initial U.S. Approval: 1982

Approved
Approval ID

83484e4b-9a8c-4125-9897-715971c7dc8c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 30, 2011

Manufacturers
FDA

Dispensing Solutions, Inc.

DUNS: 066070785

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68258-3029
Application NumberANDA078665
Product Classification
M
Marketing Category
C73584
G
Generic Name
levonorgestrel
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 30, 2011
FDA Product Classification

INGREDIENTS (7)

LEVONORGESTRELActive
Quantity: 0.75 mg in 1 1
Code: 5W7SIA7YZW
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.